from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0314c/-

LFCtreatmentdescriptionclass of inhibitor

-0.540

Amikacinug/mL Amikacintranslation

-0.669

Cap5-10ug/mL Capreomycintranslation

-1.152

Rox10-50 ug/mL Roxithromycintranslation

0.043

SM2-5 ug/mL Streptomycintranslation

-1.821

Tet5-10 ug/mL Tetracyclinetranslation

1.091

Rif0.2-5ug/mL Rifampicintranscription

-0.310

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.963

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.381

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.461

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.011

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.491

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.602

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.527

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.437

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.189

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.386

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.495

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.169

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.791

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.561

KCN5-20 ug/mL Potassium cyaniderespiration

-1.126

NaN30.2-2 mM Sodium aziderespiration

-0.591

Nigericin50 uM Nigericinrespiration

0.149

TRC10-150 ug/mL Triclosanrespiration

-1.807

TRZ10-25 ug/mL Thioridazinerespiration

-2.450

Valinomycin0.5-10 uM Valinomycinrespiration

-1.304

ZnSO42 mM ZnSO4respiration

-0.665

menadione6-10 ug/mL Menadionerespiration

0.134

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.032

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.292

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.216

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.136

NRP_1Non-replicating persistence stage 1dosRassociated

0.653

Amp0.2mg/mL AmpicillincellWall

-0.124

Cephalexin20-100 ug/mL CephalexincellWall

0.286

Cerulenin0.32-5 ug/mL CerulenincellWall

0.918

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.702

EMB10-20 ug/mL EthambutolcellWall

-0.393

Eta12-40 ug/mL EthionamidecellWall

-0.549

INH0.2-0.4 ug/mL IsoniazidcellWall

0.141

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.401

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.193

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.850

BZA0.12 mg/mL BenzamidearomaticAmides

0.954

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.189

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.601

H2O24 mM hydrogen peroxideDNAdamaging

0.419

Levo10 ug/mL LevofloxacinDNAdamaging

1.057

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-2.390

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.214

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.627

UVUV-irradiationDNAdamaging

-0.251

ARP41-4 ug/mL Antitubercular compound ARP4?

0.234

Antimycin12.5-50 ug/mL Antimycin A?

0.007

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.177

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.087

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.181

PA8240.2-2 ug/mL PA-824?

-0.536

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.093

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.331

Verapamil50 uM Verapamil?

-0.081

mercaptoethanol2 mM 2-Mercaptoethanol?

0.702

methoxatin10-20 ug/mL Methoxatin?